CLIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.306800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.974400E-01
Normal-vs-Stage2
6.046800E-01
Normal-vs-Stage3
2.065000E-01
Normal-vs-Stage4
8.840000E-01
Stage1-vs-Stage2
6.915600E-01
Stage1-vs-Stage3
2.343800E-01
Stage1-vs-Stage4
9.847400E-01
Stage2-vs-Stage3
4.961000E-01
Stage2-vs-Stage4
7.318000E-01
Stage3-vs-Stage4
5.241400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.273000E-01
Normal-vs-AfricanAmerican
6.920200E-01
Normal-vs-Asian
4.905800E-01
Caucasian-vs-AfricanAmerican
9.397200E-01
Caucasian-vs-Asian
5.613200E-01
AfricanAmerican-vs-Asian
7.995800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.363600E-01
Normal-vs-Female
6.425600E-01
Male-vs-Female
9.357200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.166400E-01
Normal-vs-Age(41-60Yrs)
9.444000E-01
Normal-vs-Age(61-80Yrs)
4.823800E-01
Normal-vs-Age(81-100Yrs)
2.490200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.820600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.285400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.790200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.223400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.363600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.658400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.607000E-01
Normal-vs-Daily Drinker
4.509400E-01
Normal-vs-Weekly Drinker
2.989400E-01
Normal-vs-Occasional Drinker
9.924800E-01
Normal-vs-Social Drinker
9.042000E-01
Non Drinker-vs-Daily Drinker
7.133200E-01
Non Drinker-vs-Weekly Drinker
9.201400E-01
Non Drinker-vs-Occasional Drinker
6.566300E-02
Non Drinker-vs-Social Drinker
1.857560E-01
Daily Drinker-vs-Weekly Drinker
8.176800E-01
Daily Drinker-vs-Occasional Drinker
1.484560E-01
Daily Drinker-vs-Social Drinker
3.295200E-01
Weekly Drinker-vs-Occasional Drinker
1.053600E-01
Weekly Drinker-vs-Social Drinker
2.728400E-01
Occasional Drinker-vs-Social Drinker
8.045400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.276760E-01
Normal-vs-Grade 2
2.048500E-02
Normal-vs-Grade 3
4.296300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.912400E-01
Grade 1-vs-Grade 3
5.508200E-01
Grade 1-vs-Grade 4
1.276760E-01
Grade 2-vs-Grade 3
5.825600E-01
Grade 2-vs-Grade 4
2.048500E-02
Grade 3-vs-Grade 4
4.296300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.814600E-01
Normal-vs-NonDiabetic
5.874400E-01
Diabetic-vs-NonDiabetic
5.365600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.440800E-01
Normal-vs-NoPancreatitis
5.662400E-01
Pancreatitis-vs-NoPancreatitis
4.134800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.628400E-01
Normal-vs-N1
6.421400E-01
N0-vs-N1
7.431000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.586000E-01
Normal-vs-TP53-NonMutant
5.771200E-01
TP53-Mutant-vs-TP53-NonMutant
4.641000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
